Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-12-28A Phase I Trial of A SRC Kinase Inhibitor, Dasatinib,in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian, Peritoneal, and Tubal Cancer
-
CLINICAL_TRIALS study record update · 2012-12-27Correlation of PTEN and IGFBP-3 in the Invasion of Ovarian Endometrioid Carcinoma
-
CLINICAL_TRIALS study record update · 2012-12-21An Ancillary Study of Patients With Advanced Stage Serous Carcinoma of the Ovary Treated on GOG Protocol 158: A Survival Analysis Based on Reclassification to a Two-tier Grading System
-
CLINICAL_TRIALS study record update · 2012-12-10A Phase II Open Label Randomised Comparative Multicentre Study to Compare the Efficacy and Tolerability of Olaparib in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Platinum Sensitive Advanced Serous Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-12-05A Phase II Study of ZD1839 (Iressa) Plus Anastrozole (Arimidex) in Patients With Relapsed Ovarian Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-11-29Phase II Evaluation of Intravenous Paclitaxel, Intraperitoneal Cisplatin, Intravenous Liposomal Doxorubicin and Intraperitoneal Paclitaxel in Women With Optimally-Debulked Stage III Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-11-29Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-11-19Phase I Trial of High-dose Topotecan in Association With Carboplatin, With Peripheral Blood Stem Cell Support in Patients With First Relapsed Ovarian Carcinoma Without Platinum-treatment Since 6-12 Months
-
CLINICAL_TRIALS study record update · 2012-11-09PHASE II STUDY OF 9-20-S-AMINO-CAMPTOTHECIN (9-AC) AS SECOND LINE THERAPY IN ADVANCED OVARIAN CARCINOMA
-
CLINICAL_TRIALS study record update · 2012-11-09Phase II Study of First-Line Therapy of Ovarian Cancer With Sequential Regimens: Cisplatin-Prolonged Oral Topotecan (C-PORT) Followed by Paclitaxel/Carboplatin (PC)
-
CLINICAL_TRIALS study record update · 2012-11-06Tissue Bank for Studies Related to Graft-Versus-Host Disease (GVHD)
-
CLINICAL_TRIALS study record update · 2012-10-26A Randomized Phase II of Zoledronic Acid (Zometa) in the Prevention of Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-10-17Phase II Trial Of Subcutaneous Amifostine For Reversal Of Persistent Paclitaxel-Induced Peripheral Neuropathy
-
CLINICAL_TRIALS study record update · 2012-10-11Addition of Vandetanib to Standard Therapy (Pegliposomal Doxorubicin) in Patients With Recurrent Ovarian Cancer. A Multicentre Phase I / Randomized Phase II Study
-
CLINICAL_TRIALS study record update · 2012-10-10Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin
-
CLINICAL_TRIALS study record update · 2012-10-05ChemoFx® PRO - A Post-Market Data Collection Study Utilizing Physician Reported Outcomes
-
CLINICAL_TRIALS study record update · 2012-10-05A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay With Progression-Free Survival in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer.
-
CLINICAL_TRIALS study record update · 2012-10-04Depression and IL-6 in Epithelial Ovarian Cancer: Genetic Diathesis and Psychological Stress
-
CLINICAL_TRIALS study record update · 2012-10-04A Study to Assess HER2-Specific T Cell Responses in Patients Receiving Trastuzumab for Solid Tumor Treatment
-
CLINICAL_TRIALS study record update · 2012-10-03Multicenter, Single-arm, Phase II Study of the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) Administered Intra- and Postoperatively in Patients With Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-09-26A Phase I/II Study of Intensive-Dose Etoposide, Topotecan and Carboplatin (ETC) Followed by Autologous Stem Cell Rescue in Chemosensitive Ovarian Cancer Patients With Either Minimal Residual Disease or at First Relapse
-
CLINICAL_TRIALS study record update · 2012-09-24A Randomized Phase III Study for the Treatment of Recurrent Epithelial Ovarian Cancer: Chemotherapy Alone Versus Chemotherapy Followed by Secondary Cytoreductive Surgery in Patients With a Treatment-Free Interval of More Than 12 Months
-
CLINICAL_TRIALS study record update · 2012-09-24Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult
-
CLINICAL_TRIALS study record update · 2012-09-24Open Label Phase II Study on RFS 2000 (9-Nitro-camptothecin, 9-NC) Administered as a "5 Days On-2 Days Off" Oral Treatment in Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-09-24Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma